Key facts
- This page summarizes Daniel M. Junius's Form 4 filing for IDEXX LABORATORIES INC /DE (IDXX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 11 May 2026, 17:10.
Daniel M. Junius - 07 May 2026 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)
- Reporting relationship
- Director
- Issuer ticker
- IDXX
- Reported as of
- 07 May 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 11 May 2026, 17:10:37 UTC
- Prior SEC filing
- 14 May 2025
- Next SEC filing
- 14 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Lily J. Lu, Attorney-in-Fact for Daniel M. Junius
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Daniel M. Junius filed Form 4 for IDEXX LABORATORIES INC /DE (IDXX) on 11 May 2026.
Change
- Previous filing in this sequence was filed on 14 May 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001094159
Primary reporting owner
JUNIUS DANIEL M
- Relationship
- Director
- Address
- ONE IDEXX DRIVE, WESTBROOK
- Signature
- /s/ Lily J. Lu, Attorney-in-Fact for Daniel M. Junius
- Signature date
- 11 May 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IDXX
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +257
- Change %
- +7.8%
- Price
- $0.000000*
- Shares after
- 3,561
- Date
- 07 May 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IDXX
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- Shares
- -257
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 07 May 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 257
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of Issuer common stock that vested in one installment on May 7, 2026.
Footnote F2
Not applicable.